Boubaker, A., Poetschger, U., Lambert, B., Castellani, M. R., Bar-Sever, Z., Oudoux, A., … Ladenstein, R. (2014). Validation of the mIBG SIOPEN Scoring Method in 2 independent High Risk Neuroblastoma Trial Populations. In EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (Vol. 41, pp. S220–S220). Gothenburg, SWEDEN: SPRINGER.

Boubaker, A., U. Poetschger, B. Lambert, M. R. Castellani, Z. Bar-Sever, A. Oudoux, A. Kaminska, et al. “Validation of the mIBG SIOPEN Scoring Method in 2 independent High Risk Neuroblastoma Trial Populations.” In EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 41:S220–S220. SPRINGER, 2014.

Boubaker A, Poetschger U, Lambert B, Castellani MR, Bar-Sever Z, Oudoux A, et al. Validation of the mIBG SIOPEN Scoring Method in 2 independent High Risk Neuroblastoma Trial Populations. In: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. SPRINGER; 2014. p. S220–S220.

Boubaker, A., et al. “Validation of the mIBG SIOPEN Scoring Method in 2 independent High Risk Neuroblastoma Trial Populations.” EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, vol. 41, SPRINGER, 2014, pp. S220–S220.

Boubaker A, Poetschger U, Lambert B, Castellani MR, Bar-Sever Z, Oudoux A, Kaminska A, Taborska K, Kreissman SG, Yanik G, Matthay KK, Naranjo A, Park JR, Valteau-Couanet D, Ladenstein R. Validation of the mIBG SIOPEN Scoring Method in 2 independent High Risk Neuroblastoma Trial Populations. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. SPRINGER; 2014. p. S220–S220.